Full Press Release Details
LIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED FIRST QUARTER REVENUE
Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue
San Diego, CA, October 15, 2009, LifeVantage Corporation (OTCBB: LFVN), the maker of Protandim and
TrueScience Anti-Aging Cream, science-based solutions to oxidative stress, announced preliminary unaudited net revenue
for the first fiscal quarter of 2010. The Company anticipates net revenue of approximately $1.9 million for the three
month period ended September 30, 2009, compared to net revenue of $1.6 million for the three month period ended June
30, 2009. This continued growth in revenue demonstrates the success of the Company s on-going expansion into the
network marketing distribution model.
Total operating expenses in the first fiscal quarter of 2010 decreased by approximately 25% from total operating
expenses of $6.1 million in the fourth fiscal quarter of 2009. This decline is primarily attributable to reductions of
approximately 80% in total legal expenses. In the first fiscal quarter of 2010, legal expenses decreased by
approximately $1 million and other operating expenses decreased by approximately $0.5 million. These decreases are
directly attributable to the Company s efforts in expense reductions and greatly reduced activity in litigation in
which the Company has been a party.
We are pleased to announce that the Company anticipates its second consecutive quarter of double digit percentage
increases in net revenue, stated Carrie E. Carlander, Chief Financial Officer of LifeVantage, especially since both
quarters of revenue increases occurred during a traditionally slower time of year for MLM companies. Moving forward, as
we continue to grow and expand our network marketing business model and make progress on the scientific front, we will
continue to look for ways to decrease expenditures as appropriate as we move towards profitability.
The Company will hold a conference call today at 1:30pm Pacific time (4:30pm Eastern time) during which it will provide
an update on its business and discuss fourth quarter and fiscal year 2009 financial and operating results as well as
preliminary unaudited financial results for the first fiscal quarter of 2010. David W. Brown, President Chief
Executive Officer, is scheduled to lead the call and will be joined by Carrie E. Carlander, Chief Financial Officer.
The conference call may be accessed by dialing (888) 857-6930 for domestic callers and entering the pass code 5862542.
The webcast will be available live via the Internet by accessing the Investors section of LifeVantage s website at
http://www.lifevantage.com/investor-profile.aspx. Replays of the webcast will be available on LifeVantage s
website for 30 days and a phone replay will be available through October 20th, 2009 by dialing (888)
203-1112 and entering the pass code 5862542.
About LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, nutraceutical company dedicated to helping
people reach their health and wellness goals. Founded in 2003 and based in San Diego, CA, LifeVantage develops
products, including Protandim , that deliver significant health benefits to consumers. For more information,
visit www.LifeVantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current
prospects, as well as words such as believe, hopes, intends, estimates, expects, projects, plans,
anticipates and variations thereof, identify forward-looking statements, but their absence does not mean that a
statement is not forward-looking. Such forward-looking statements are not guarantees of performance and the Company s
actual results could differ materially from those contained in such statements. These forward-looking statements are
based on the Company s current expectations and beliefs concerning future events affecting the Company and involve
known and unknown risks and uncertainties that may cause the Company s actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks and uncertainties include, among others, the
potential failure or unintended negative consequences of the implementation of our network marketing sales channel; our
ability to retain independent distributors or to attract new independent distributors on an ongoing basis; the
potential for third party and governmental actions involving our network marketing sales channel; the potential for
product liability claims against the Company; the risk that government regulators and regulations could adversely
affect our business; future laws or regulations may hinder or prohibit the production or sale of our existing product and any future products; unfavorable
publicity could materially hurt our business; and the Company s ability to protect our intellectual property rights and
the value of our product. These and other risk factors are discussed in greater detail in the Company s Annual Report on
Form 10-K and Quarterly Report on Form 10-Q under the caption Risk Factors , and in other documents filed by the
Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place
undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based
on information currently available to the Company on the date hereof, and the Company undertakes no obligation to
revise or update these forward-looking statements to reflect events or circumstances after the date of this document,
except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to
diagnose, treat, cure or prevent any disease.
Investor Relations Contact:
(858) 312-8000 Ext. 4